Search results for " Screening"

showing 10 items of 898 documents

Design, synthesis, DNA-binding and cytotoxicity evaluation of new potential combilexines

2002

Combilexines, compounds in which a DNA intercalator is linked to a minor groove binding component, interact with the DNA in a sequence specific manner to yield in most cases compounds with anticancer activity. A series of new compounds closely related to netropsin in which the two components were linked by an amide group was synthesised as potential combilexines. As some of these compounds showed cytotoxic activity in vitro, an attempt was made to rationalise their mechanism of action. The DNA binding characteristics of the carboxamides were evaluated by thermal denaturation experiments and by ethidium bromide displacement assay. Their ability to inhibit the topoisomerase I was also determi…

medicine.drug_classStereochemistryAntineoplastic AgentsCarboxamideNucleic Acid DenaturationChemical synthesischemistry.chemical_compoundDrug DiscoveryTumor Cells CulturedmedicineA-DNAPharmacologyBinding SitesbiologyTopoisomeraseOrganic ChemistryDNAGeneral MedicineIntercalating AgentschemistryMechanism of actionBiochemistryNetropsinDrug Designbiology.proteinDrug Screening Assays AntitumorTopoisomerase I Inhibitorsmedicine.symptomEthidium bromideCell DivisionDNAEuropean Journal of Medicinal Chemistry
researchProduct

Development and biological investigations of hypoxia-sensitive prodrugs of the tyrosine kinase inhibitor crizotinib

2019

Despite the huge success of tyrosine kinase inhibitors as anticancer agents, severe side effects are a major problem. In order to overcome this drawback, the first hypoxia-activatable 2-nitroimidazole-based prodrugs of the clinically approved ALK and c-MET inhibitor crizotinib were developed. The 2-aminopyridine functionality of crizotinib (essential for target kinase binding) was considered as ideal position for prodrug derivatization. Consequently, two different prodrugs were synthesized with the nitroimidazole unit attached to crizotinib either via carbamoylation (A) or alkylation (B) of the 2-aminopyridine moiety. The successful prodrug design could be proven by docking studies and a dr…

medicine.drug_classTyrosine kinase inhibitorAntineoplastic Agents01 natural sciencesBiochemistryArticleTyrosine-kinase inhibitorStructure-Activity Relationshipchemistry.chemical_compoundDrug DevelopmentCrizotinibIn vivoDrug DiscoverymedicineHumansAnaplastic Lymphoma KinaseProdrugsHypoxiaProdrugProtein Kinase InhibitorsMolecular BiologyCells CulturedCell ProliferationNitroimidazoleDose-Response Relationship DrugMolecular StructureCrizotinib010405 organic chemistryChemistryNitroimidazoleOrganic ChemistryProto-Oncogene Proteins c-metProdrugCell Hypoxia0104 chemical sciences010404 medicinal & biomolecular chemistrySettore CHIM/03 - Chimica Generale E InorganicaDocking (molecular)Cancer researchDrug Screening Assays AntitumorKinase bindingTyrosine kinasemedicine.drugBioorganic Chemistry
researchProduct

The definition, screening, and treatment of postpartum anemia: A systematic review of guidelines.

2020

Background: Postpartum anemia can negatively affect maternal health and interfere with early parenting. Thus, it is important to have clear, evidence-informed recommendations on its diagnosis and treatment. Objective: To compare global recommendations regarding the appropriate management of postpartum anemia and to highlight similarities and differences. Methods: Systematic searches were conducted in the databases PubMed, CINAHL, LILACS, TRIP database, and Scopus, and in the websites of health institutions and scientific societies. Search terms were related to anemia and the postpartum period. Two hundred and eighty papers were identified; the full texts of 30 sets of guidelines were review…

medicine.medical_specialty030219 obstetrics & reproductive medicineAnemiabusiness.industryPostpartum PeriodScopusObstetrics and GynecologyAnemiaCINAHL030204 cardiovascular system & hematologymedicine.diseaseAffect (psychology)03 medical and health sciences0302 clinical medicineFamily medicineScale (social sciences)medicineHumansMass ScreeningMaternal healthProfessional associationFemalebusinessPostpartum periodBirth (Berkeley, Calif.)References
researchProduct

Verbesserte Auswertbarkeit transitorisch evozierter otoakustischer Emissionen durch Korrelationsfilterung

1993

Hearing screening as well as evaluation of cochlear function under therapy with ototoxic agents or patients with various diseases is increasingly done by registration of transient evoked otoacoustic emissions (TEOAE). Usually the standard system ILO 88 Otodynamic Analyser is used, where until now emissions were analyzed subjectively. However, evaluation of signals may be difficult mainly in the hearing threshold area. In this article we describe a method to mathematically analyze registered emissions by correlation-filtering. This allows to better identify small specific responses, to further increase the sensitivity of TEOAE, and offers a more objective means for audiologic diagnoses.

medicine.medical_specialtyAbsolute threshold of hearingElectrodiagnosismedicine.diagnostic_testbusiness.industryOtoacoustic emissionAudiologyHearing screeningCochlear functionStandard systemCorrelationOtorhinolaryngologyReference valuesmedicinebusinessLaryngo-Rhino-Otologie
researchProduct

IFN-alpha Stimulates Proliferation and Cytokine Secretion of CD40-Stimulated B Cell Chronic Lymphocytic Leukemia Cells In Vitro

1999

Interferon (IFN)-alpha has a therapeutic effect in several B cell malignancies, including low-grade non-Hodgkin's lymphoma (NHL), multiple myeloma, and hairy cell leukemia, whereas its efficacy in the treatment of B cell chronic lymphocytic leukemia (B-CLL) is rather limited. In the present study, we investigated the effect of IFN-alpha on the biologic functions of B-CLL cells, which were stimulated by cross-linking of the CD40 antigen. In cell samples from 16 B-CLL patients, the addition of IFN-alpha to CD40-stimulated purified B-CLL cells caused a significant increase in [3H]thymidine uptake (p < 0.003). In B-CLL cells maximally activated by CD40 cross-linking and interleukin-2 (IL-2)/IL-…

medicine.medical_specialtyAdoptive cell transferImmunologyNaive B cellAntineoplastic Agentsimmune system diseaseshemic and lymphatic diseasesVirologyInternal medicineTumor Cells CulturedmedicineHumansHairy cell leukemiaCD40 AntigensCells CulturedB cellCD20B-LymphocytesCD40biologyChemistryInterferon-alphaCell Biologymedicine.diseaseLeukemia Lymphocytic Chronic B-CellStimulation ChemicalClone CellsEndocrinologymedicine.anatomical_structurebiology.proteinCancer researchCytokinesCytokine secretionDrug Screening Assays AntitumorCD5Cell DivisionJournal of Interferon &amp; Cytokine Research
researchProduct

Long-term care of AIDS and non-communicable diseases.

2011

medicine.medical_specialtyAnti-HIV AgentsDeveloping countryMedically Underserved AreaUterine Cervical NeoplasmsZambiaComorbidityHealth servicesAcquired immunodeficiency syndrome (AIDS)Cause of DeathMedicineHumansMass ScreeningIntensive care medicineDeveloping CountriesAcquired Immunodeficiency SyndromeHealth Services Needs and Demandbusiness.industryCancerGeneral Medicinemedicine.diseaseLong-term careFamily medicineChronic DiseaseFeasibility StudiesFemalebusinessLancet (London, England)
researchProduct

Critical Issues in Peripheral Arterial Disease Detection and Management&lt;subtitle&gt;A Call to Action&lt;/subtitle&gt;

2003

Jill J. F. Belch, MD; Eric J. Topol, MD; Giancarlo Agnelli, MD; Michel Bertrand, MD; Robert M. Califf, MD; Denis L. Clement, MD; Mark A. Creager, MD; J. Donald Easton, MD; James R. Gavin III, MD, PhD; Philip Greenland, MD; Graeme Hankey, MD; Peter Hanrath, MD; Alan T. Hirsch, MD; Jurgen Meyer, MD; Sidney C. Smith, MD; Frank Sullivan, PhD; Michael A. Weber, MD; for the Prevention of Atherothrombotic Disease Network

medicine.medical_specialtyAtherothrombotic diseasebusiness.industryArterial diseaseMedical screeningOcclusive arterial diseaseIschemic strokeInternal MedicinemedicineTheologybusinessMass screeningSurgeryArchives of Internal Medicine
researchProduct

Breast cancer screening programmes: Challenging the coexistence with opportunistic mammography.

2014

Abstract Objective This study investigated predictive factors of women's participation in organized mammography screening (OrgMS) and/or opportunistic mammography screening (OppMS) when the two screening modes coexist. Methods Questionnaires were sent to 6,000 women aged 51–74 years old invited to attend an OrgMS session between 2010 and 2011 in France. Data collected concerned the women's healthcare behaviour and their socioeconomic characteristics. Women without a personal or family history of breast cancer that could explain their participation in OppMS were retained in the generalized logits analysis. Results The data of 1,202 women were analysed. Of these, 555 (46.2%) had attended OrgM…

medicine.medical_specialtyBreast NeoplasmsMedical OveruseBreast cancer screeningBreast cancer5. Gender equalitySurveys and QuestionnairesCancer screeningHealth careHumansMass ScreeningMedicineMammographyFamily historySocioeconomic statusEarly Detection of CancerComputingMilieux_MISCELLANEOUSAgedmedicine.diagnostic_testbusiness.industry[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieGeneral MedicineMiddle Agedmedicine.disease3. Good healthSocioeconomic Factors[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieFamily medicinePhysical therapyFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFranceMammography screeningPatient ParticipationbusinessMammography
researchProduct

Screening and surveillance for hepatocellular carcinoma: perspective of a new era?

2016

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third most common cause of cancer-related death with an increasing prevalence worldwide. Early diagnosis of HCC is important since observational studies have reported that, in patients undergoing surveillance, cancer is diagnosed at an earlier stage with increased chances of curative therapies. Anyway, despite the extensive use of screening for HCC, its effectiveness is still a controversial topic since supporting evidence is not unequivocal and some issues need to be explored. Areas covered: The aim of this paper is to review main literature data supporting performance and effectiveness of screening for early detection …

medicine.medical_specialtyCarcinoma HepatocellularEarly detectionGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansMass ScreeningPharmacology (medical)In patientStage (cooking)Intensive care medicineCancer specific mortalityEarly Detection of CancerNeoplasm StagingRandomized Controlled Trials as Topicbusiness.industryLiver NeoplasmsCancermedicine.diseasedigestive system diseasesOncology030220 oncology & carcinogenesisHepatocellular carcinomaPopulation Surveillance030211 gastroenterology & hepatologyObservational studybusinessExpert review of anticancer therapy
researchProduct

Physical exercise program, a strategy to prevent cardiotoxicity in early breast cancer: A literature review

2018

Breast cancer, the most common in women, is a cancer of good prognosis. During this last decade, the improvement of cancer screening and treatment has significantly increased disease-free and overall survival. However, the chemotherapy, especially based on anthracyclines, and targeted therapies like trastuzumab have a toxicity to the cardiovascular system. If physical exercise is recognized as beneficial in tertiary prevention, especially by reducing fatigue, improving the physiological capacities of exercise, muscle strength and ultimately quality of life, conversely, few data are available on the effects of exercise on treatment-induced cardiotoxicity. This review, based on the PubMed dat…

medicine.medical_specialtyCardiotoxicityPhysiologybusiness.industryCancerPhysical Therapy Sports Therapy and RehabilitationPhysical exercise030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicineBreast cancerQuality of lifeTrastuzumab030220 oncology & carcinogenesisPhysiology (medical)Cancer screeningmedicineOrthopedics and Sports MedicinebusinessIntensive care medicineTertiary Preventionmedicine.drugMovement &amp; Sport Sciences - Science &amp; Motricité
researchProduct